Clinical evaluation of clobetasone butyrate eye drops in episcleritis.

AUTOR(ES)

Lloyd-Jones, D

RESUMO

Thirty-nine patients took part in a double-blind, between-patient clinical trial to compare clobetasone butyrate, betamethasone phosphate, and placebo eye drops in the treatment of episcleritis. Although from the symptom scores the patients given placebo appeared to do as well as the other patients in the first week of treatment, they did significantly less well after this time. Clobetasone butyrate and betamethasone phosphate eye drops seemed to be equally effective in the treatment of this disease.

Documentos Relacionados

• Clinical evaluation of clobetasone butyrate eye drops in the treatment of anterior uveitis and its effects on intraocular pressure.
• Scleritis and episcleritis.
• Corneal sensation in scleritis and episcleritis.
• Clinical evaluation of clobetasone butyrate: a comparative study of its effects in postoperative inflammation and on intraocular pressure.
• Concentration of clobetasone butyrate in aqueous humour.